In addition, inactivating mutations in MLH1 are the main cause of Lynch syndrome, characterized by autosomal dominant inheritance of early-onset colorectal cancer (CRC) and associated with increased risk of other cancers, and its promoter region is often epigenetically silenced in a variety of sporadic cancers [145] (see also Table S1 and Figure S1). Here, MLH1 is linked to cancer.